Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
Implitapide in hypertriglyceridemia
NCT00080132Phase 2Terminated
- Sponsor
- Medical Research Laboratories International
- Start
- Oct 2004
- Countries
- 3
01
Overview
Phase 2, open-label, single-arm trial of implitapide in hypertriglyceridemia, sponsored by Medical Research Laboratories International. Primary endpoints: Triglyceride levels and Safety and tolerability. Started Oct 2004; status: terminated.
02
Drugs
implitapide
03
Conditions
hypertriglyceridemia
Beyond the preview
Go deeper on NCT00080132.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on NCT00080132.